Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer AG

www.bayer.com

Latest From Richard Wolf Medical Instruments Corp.

Market Dynamics Switchover To Come In Fast-Growing Soft Tissue Fixation Segment

Global sales for arthroscopy and sports medicine devices are predicted to hit $6.5bn by 2021. This will be driven by the fast-growing soft tissue fixation products segment: significant changes in market dynamics are expected over the next few years, as hip fixation procedures pick up pace. This article delves into the landscape of the soft tissue fixation device market, as well as the four key segments in the arthroscopy devices space. It will also analyze the key players in these markets, highlight trends and discuss the biggest challenges.

Orthopedics Surgical Procedures

Lawmaker Asks FDA To Launch Criminal Inquiry Into Power Morcellators

Rep. Mike Fitzpatrick, R-Pa., is asking FDA's criminal office to investigate whether Ethicon and several East Coast hospitals fulfilled safety reporting requirements for power morcellators, which have been linked to a risk of spreading cancer in women undergoing treatment for uterine fibroids.

Medical Device Legislation

Warning Letter Close-Outs – June 2015

Five FDA medical device close-out letters were released in June.

Medical Device Regulation

New York Senators Urge Withdrawal Of All Power Morcellators For Fibroids

New York Sens. Kirsten Gillibrand (D) and Charles Schumer (D) request that FDA ask all makers of power morcellators for removal of uterine fibroids to withdraw the devices from the market in the wake of studies showing uterine cancer risks.

Medical Device Regulation
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register